Introduction
Health insurance payer CEOs command some of the highest salaries in corporate America. In 2025, their compensation packages reflected both performance and leadership transitions. This article breaks down the top-earning payer CEOs, their total packages, and what drives these numbers.
Why CEO Pay Matters in Healthcare
CEO compensation signals strategic priorities. Moreover, it reflects how boards value leadership during volatile periods. Health insurance companies face rising costs, regulatory pressure, and enrollment shifts. Therefore, attracting top talent comes at a premium. Understanding these pay structures helps analysts, employees, and policymakers assess industry direction.
Additionally, payer CEO pay sparks public debate. Critics argue high salaries conflict with patient affordability goals. Supporters, however, say competitive pay secures the leaders who manage billion-dollar systems. Both perspectives deserve consideration.
Stephen Hemsley Leads the List
UnitedHealth Group’s Return CEO Takes the Top Spot
Stephen Hemsley earned the most among all payer CEOs in 2025. His total compensation reached $60,938,062. That figure stands far above every other executive on this list.
Hemsley returned to the CEO role at UnitedHealth Group in 2025. To mark his return, the board granted him a one-time equity award of $60,000,024. His base salary was $596,154. Other compensation added $341,884.
This one-time award explains his dominant position. Without it, his salary alone would rank far lower. Notably, that award reflects the board’s confidence in his leadership comeback.
Compensation Breakdown:
- Salary: $596,154
- Option Awards: $60,000,024
- Other Compensation: $341,884
- Total: $60,938,062
Andrew Witty Ranks Second
Former UnitedHealth Group CEO Still Earns Significantly
Andrew Witty, the former CEO of UnitedHealth Group, ranked second overall. His total compensation came to $24,599,372. He stepped down during 2025, yet still received a substantial package.
His pay included a base salary of $903,846, stock awards of $17,250,591, and option awards of $5,750,048. Other compensation added $694,887.
Compensation Breakdown:
- Salary: $903,846
- Stock Awards: $17,250,591
- Option Awards: $5,750,048
- Other Compensation: $694,887
- Total: $24,599,372
David Cordani and Cigna Group
Cigna CEO Earns Over $22 Million
David Cordani of Cigna Group ranked third. His total package reached $22,866,134. Cordani earned a base salary of $1,600,000. Furthermore, he received stock awards of $13,929,161 and option awards of $3,400,019.
Non-equity incentive compensation added $3,200,000. Pension value changes contributed $97,562. Other compensation rounded out his package at $639,392.
Compensation Breakdown:
- Salary: $1,600,000
- Stock Awards: $13,929,161
- Option Awards: $3,400,019
- Non-Equity Incentive: $3,200,000
- Pension & Deferred Compensation: $97,562
- Other Compensation: $639,392
- Total: $22,866,134
Gail Boudreaux at Elevance Health
Elevance CEO Sees Pay Increase from 2024
Gail Boudreaux ranked fourth. Her total compensation for 2025 was $22,582,314. Boudreaux received a pay bump compared to her 2024 earnings. Her salary held steady at $1,600,000. Additionally, she earned stock awards of $13,440,277 and option awards of $4,199,765.
Non-equity incentive plan compensation contributed $2,788,000. Other compensation added $574,272.
Compensation Breakdown:
- Salary: $1,600,000
- Stock Awards: $13,440,277
- Option Awards: $4,199,765
- Non-Equity Incentive: $2,788,000
- Other Compensation: $574,272
- Total: $22,582,314
David Joyner Leads CVS Health
CVS CEO Earns Over $21 Million
David Joyner of CVS Health ranked fifth. His total compensation was $21,214,084. Joyner drew a base salary of $1,500,000. Moreover, he received the largest stock award in this tier at $14,499,931. His non-equity incentive plan compensation reached $4,695,900. Other compensation added $453,609.
CVS Health CEO pay also rose from the prior year. This increase reflects the company’s continued strategic transformation under Joyner’s leadership.
Compensation Breakdown:
- Salary: $1,500,000
- Stock Awards: $14,499,931
- Non-Equity Incentive: $4,695,900
- Other Compensation: $453,609
- Total: $21,214,084
Sarah London of Centene
Centene CEO Ranks Sixth with $19.5 Million Package
Sarah London ranked sixth. Her total compensation reached $19,506,298. London earned a base salary of $1,473,077. In addition, she received stock awards of $15,537,733 — the highest stock award value among all executives ranked sixth through eighth.
Non-equity incentive plan compensation added $2,109,446. Other compensation contributed $386,042.
Compensation Breakdown:
- Salary: $1,473,077
- Stock Awards: $15,537,733
- Non-Equity Incentive: $2,109,446
- Other Compensation: $386,042
- Total: $19,506,298
Jim Rechtin at Humana
Humana CEO Earns Nearly $19 Million
Jim Rechtin ranked seventh on this list. His total compensation was $18,757,075. Rechtin’s base salary came to $1,348,558. Furthermore, Humana’s pay structure mirrors industry trends, combining salary with large stock awards.
He received stock awards of $13,868,141. Non-equity incentive plan compensation added $3,034,740. Other compensation rounded up to $505,636. Humana CEO pay also rose compared to 2024 figures.
Compensation Breakdown:
- Salary: $1,348,558
- Stock Awards: $13,868,141
- Non-Equity Incentive: $3,034,740
- Other Compensation: $505,636
- Total: $18,757,075
Joseph Zubretsky at Molina Healthcare
Molina CEO Rounds Out the Top Eight
Joseph Zubretsky ranked eighth. His total compensation was $18,340,783. Notably, Zubretsky earned the highest base salary in the bottom half of this list at $1,600,000. His stock awards totaled $16,199,988 — the largest stock award on the entire list after Centene.
Other compensation contributed $540,795. Zubretsky did not receive a separate non-equity incentive plan payment in this reporting period.
Compensation Breakdown:
- Salary: $1,600,000
- Stock Awards: $16,199,988
- Other Compensation: $540,795
- Total: $18,340,783
Key Takeaways on Payer CEO Pay
Several clear trends emerge from this data. First, stock awards drive the largest share of total compensation for most executives. Second, base salaries remain relatively consistent across the group, ranging from $1.3 million to $1.6 million. Third, one-time equity grants — as seen with Hemsley — can dramatically inflate total pay figures.
Additionally, pay bumps from 2024 appear at Elevance Health, CVS Health, and Humana. This reflects strong board confidence in current leadership. Consequently, industry watchers expect compensation levels to remain elevated as payers navigate cost pressures, Medicare Advantage shifts, and post-ACA regulatory changes.
In summary, payer CEO compensation in 2025 reflects both individual performance and broader market forces shaping American healthcare.
